Ultragenyx Pharmaceutical Inc. buy TD Cowen
Start price
05.11.25
/
50%
€27.80
Target price
05.11.26
€65.26
Performance (%)
-28.53%
Price
10.04.26
€19.70
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -28.53%. This prediction currently runs until 05.11.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.073% | 2.073% |
| iShares Core DAX® | 2,55 % | 0,56 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % |
| iShares S&P 500 | 1,93 % | -0,51 % |
Comments by TD_Cowen for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at TD Cowen from $86.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by TD_Cowen for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.00
21.10.24
21.10.24
€67.47
21.10.25
21.10.25
-41.20%
22.10.25
22.10.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.20
24.04.24
24.04.24
€57.02
24.04.25
24.04.25
-20.39%
25.04.25
25.04.25